Cytek Biosciences Inc
NASDAQ:CTKB

Watchlist Manager
Cytek Biosciences Inc Logo
Cytek Biosciences Inc
NASDAQ:CTKB
Watchlist
Price: 4.86 USD -2.21% Market Closed
Market Cap: 621.4m USD

Intrinsic Value

The intrinsic value of one CTKB stock under the Base Case scenario is 3.24 USD. Compared to the current market price of 4.86 USD, Cytek Biosciences Inc is Overvalued by 33%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CTKB Intrinsic Value
3.24 USD
Overvaluation 33%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cytek Biosciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CTKB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CTKB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Cytek Biosciences Inc.

Explain Valuation
Compare CTKB to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CTKB?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cytek Biosciences Inc

Current Assets 388.5m
Cash & Short-Term Investments 261.7m
Receivables 57.4m
Other Current Assets 69.4m
Non-Current Assets 106.4m
PP&E 29.2m
Intangibles 34.4m
Other Non-Current Assets 42.9m
Current Liabilities 75.2m
Accounts Payable 7.6m
Accrued Liabilities 26.3m
Other Current Liabilities 41.3m
Non-Current Liabilities 41.1m
Long-Term Debt 655k
Other Non-Current Liabilities 40.5m
Efficiency

Free Cash Flow Analysis
Cytek Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cytek Biosciences Inc

Revenue
196.8m USD
Cost of Revenue
-91.6m USD
Gross Profit
105.2m USD
Operating Expenses
-137m USD
Operating Income
-31.8m USD
Other Expenses
19m USD
Net Income
-12.8m USD
Fundamental Scores

CTKB Profitability Score
Profitability Due Diligence

Cytek Biosciences Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Net Margin
Declining Gross Margin
30/100
Profitability
Score

Cytek Biosciences Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

CTKB Solvency Score
Solvency Due Diligence

Cytek Biosciences Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Negative Net Debt
Low D/E
77/100
Solvency
Score

Cytek Biosciences Inc's solvency score is 77/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CTKB Price Targets Summary
Cytek Biosciences Inc

Wall Street analysts forecast CTKB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CTKB is 5.87 USD with a low forecast of 4.04 USD and a high forecast of 7.88 USD.

Lowest
Price Target
4.04 USD
17% Downside
Average
Price Target
5.87 USD
21% Upside
Highest
Price Target
7.88 USD
62% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cytek Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CTKB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CTKB Insider Trading
Buy and sell transactions by insiders

CTKB News

Other Videos
What is the Intrinsic Value of one CTKB stock?

The intrinsic value of one CTKB stock under the Base Case scenario is 3.24 USD.

Is CTKB stock undervalued or overvalued?

Compared to the current market price of 4.86 USD, Cytek Biosciences Inc is Overvalued by 33%.

Back to Top